Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Haematologica
|
December 4, 2008
Treatment of chronic myeloid leukemia in blast crisis
R Hehlmann, S Saussele
Bone Marrow Transplantation
|
March 29, 2011
Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors
S Saussele, R Hehlmann, A Gratwohl, et al.
Annals of Hematology
|
May 6, 2004
Monitoring of minimal residual disease in acute promyelocytic leukemia
E Lengfelder, A Reiter, S Saussele, et al.
Leukemia
|
May 21, 2011
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia
M Pfirrmann, A Hochhaus, M Lauseker, et al.
Leukemia
|
June 25, 1998
Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation
A Krämer, A Hochhaus, S Saussele, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
September 26, 1997
Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy
A Hochhaus, A Reiter, H Skladny, et al.
Virus Genes
|
January 1, 1997
Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues
A Willer, S Saussele, W Gimbel, et al.
Leukemia
|
April 1, 1994
Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group
R Hehlmann, P Kister, A Willer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2017
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Hochhaus, S Saussele, G Rosti, et al.
British Journal of Cancer
|
May 13, 2004
Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer
R-D Hofheinz, A Willer, A Weisser, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Haematologica
|
December 4, 2008
Treatment of chronic myeloid leukemia in blast crisis
R Hehlmann, S Saussele
Bone Marrow Transplantation
|
March 29, 2011
Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors
S Saussele, R Hehlmann, A Gratwohl, et al.
Annals of Hematology
|
May 6, 2004
Monitoring of minimal residual disease in acute promyelocytic leukemia
E Lengfelder, A Reiter, S Saussele, et al.
Leukemia
|
May 21, 2011
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia
M Pfirrmann, A Hochhaus, M Lauseker, et al.
Leukemia
|
June 25, 1998
Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation
A Krämer, A Hochhaus, S Saussele, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
September 26, 1997
Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy
A Hochhaus, A Reiter, H Skladny, et al.
Virus Genes
|
January 1, 1997
Two groups of endogenous MMTV related retroviral env transcripts expressed in human tissues
A Willer, S Saussele, W Gimbel, et al.
Leukemia
|
April 1, 1994
Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group
R Hehlmann, P Kister, A Willer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2017
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Hochhaus, S Saussele, G Rosti, et al.
British Journal of Cancer
|
May 13, 2004
Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer
R-D Hofheinz, A Willer, A Weisser, et al.
Page
of 4